First-line PARP inhibitor maintenance after platinum chemotherapy reduces progression risk in certain patients with ovarian ...
Barbera credits Dr. Donna Klobocista’s compassionate guidance before surgery for giving her confidence; now she mentors others facing ovarian cancer. When Mary Barbera was diagnosed with stage 3C ...
Tesaro’s experimental ovarian cancer drug niraparib proved to significantly lengthen progression-free survival time in patients during a recent Stage 3 trial. The study included more than 500 patients ...
The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer. High-level results from a phase 3 trial ...
1don MSN
One woman tells her story about how incredibly thankful she is after surviving ovarian cancer
SAN ANTONIO — Thanksgiving is a holiday that is centered around gatherings, including food, family, and friends. Meet the San ...
Mirvetuximab soravtansine (MIRV; Elahere; AbbVie) demonstrated significant efficacy and an acceptable safety profile in the treatment of recurrent ovarian cancer, showing particular promise in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback